Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 7, 2016; 22(45): 9909-9920
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.9909
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.9909
Table 1 Characteristics of four stages in portal biliopathy natural history
Stage | Portal cavernoma | Biliopathy | LFTs | Symptoms | Complications |
Preclinic | Yes | No | Normal | No | No |
Asymptomatic | Yes | Early changes | Normal or abnormal | No | No |
Symptomatic | Yes | Advanced changes | Abnormal | Yes | No |
Complicated | Yes | Advanced changes | Abnormal | Yes | Yes |
Table 2 Endoscopic management of portal biliopathy: summary of case series
Ref. | No. of patients | Biliary abnormalities | First treatment | Follow-up | Further treatments | Complications/outcome |
Bhatia et al[27], 1995 | 4 symptomatic | Stenosis + stones 3 CBD stones 4 | ES + SE + NBD 4 | 3-8 mo | Multiple ERCP 4 | None |
Perlemuter et al[20], 1996 | 8 symptomatic | Stenosis 8 CBD stones 2 Cholangitis 1 | ES+NBD 3 BD 1 PSS 1 UDCA 2 | 6-60 mo | Multiple ES 1 | Death 2 (cholangitis 1; stroke 1) |
Condat et al[3], 2003 | 7 symptomatic | Cholecystitis/right hypocondrial pain 4 Cholangitis 1 Stenosis 2 | Cholecystostomy + SE 1 Stent 1 BA + PTBD 1 UDCA 4 | 4-25 mo | - | Haemobilia 1 |
Sezgin et al[28], 2003 | 10 symptomatic | Stenosis 9 IE stones 1 | ES + stent 10 NBD 4 BD 4 | 3.3 yr (range 1-7) | Multiple ERCP 5 | Haemobilia 1 Cholangitis 5 Death 1 |
Dumortier et al[22], 2003 | 6 symptomatic | Stenosis 5 CBD stones 2 | ES 5 BD 5 SE 2 Stent 1 | 10 mo (range 2 d-18 mo) | Multiple ERCP + PSS 4 | Cholangitis 1 Cholecystitis 4 |
Khare et al[25], 2005 | 13 symptomatic | Stenosis 10 CBD stones 8 | Stent 4 BD 6 SE 4 | - | PSS 8 BA 1 Multiple ERCP 2 Splenectomy + devasc 2 | Death 1 |
Dhiman et al[29], 2007 | 12 symptomatic | Stenosis 7 CBD stones 5 CBD varices 1 Mirizzi’ssdr 1 | PSS 5 ES 3 ES + BD 2 Stent 4 | 19 mo (6-132 mo) | Multiple ERCP in pts initially treated with stent | Cholangitis in 2 pts treated with stent |
Vibert et al[30], 2007 | 19 symptomatic | IE biliary dilation 9 IE stones 7 CBD stones 4 | PSS group: PTBD 1 SRS 10 NPSS group: ES + stent 2 ES + SE 1 PTBD 6 BA 4 | 19 pts 8.3 yr | PSS group: BA 5 NPSS group PTBD 1 after ERCP and 4 after BA | Resolution 17 Death 3 |
Oo et al[17], 2009 | 13 symptomatic | Stenosis 13 CBD stones 10 GB stones 11 | UDCA 1 Stent 7 ES + SE 1 Failed ERCP 4 | 2 yr (1-18 aa) | Metallic stent 3 Stent exchange 2 PSS 3 (2 TIPS, 1 surgical) LT 1 | Haemobilia 2 Sepsis 3 |
Llop et al[1], 2011 | 14 symptomatic | Stenosis 14 CBD stones 6 GB stones 2 | ES + SE 6 ES + UDCA 2 Cholecystectomy 2 | - | Multiple ERCP 1 BA 1 | - |
Saraswat et al[24], 2013 | 20 symptomatic | Stenosis 20 CBD stones 8 GB stones 6 | ES + SE 8 Stent 9 BD + stent 11 | 18 mesi (range 3-188) | Multiple ERCP 11 | In 130 procedures: Cholangitis 40 Haemobilia 9 |
Ramchandani et al[31], 2013 | 5 symptomatic | CBD stenosis 2 CHD stenosis 1 CBD stones 2 | Metallic stent 1 Plastic stent 2 BD + stent 1 Intracholedocal lithotripsy 1 | 6-7 mo | SRS 2 Stent Exchange 1 | - Resolution 5 |
Cellich et al[23], 2015 | 8 symptomatic 1 asymptomatic | Stenosis 7 CBD stones 3 GB stones 1 | ES 7 BD 4 SE 2 Stent 7 | - | PSS 1 Stent exchange 3 BA 3 | Cholangitis 3 Haemobilia 1 |
Table 3 Endoscopic management of portal biliopathy: summary of case reports
Ref. | Patients | Biliary abnormalities | First treatment | Follow-up | Further treatment | Complications |
Mörk et al[32], 1998 | 2 | CBD stenosis 2 | Stent 2 | - | Multiple Stent exchange + PSS 1 | Cholangitis 1 |
Solmi et al[33], 1998 | 1 | Stenosis | Stent | - | - | - |
Mutignani et al[34], 2002 | 3 | CBD stenosis 3 | Stent 3 | - | PSS 3 | Haemobilia 3 |
Perego et al[35], 2003 | 1 | Stenosis + CBD stones | - Stent | 3 yr | Multiple stent exchange→PTBD + dilation and SE | - |
Umphress et al[15], 2004 | M, 62 yr | IE and CBD stones | ES + SE + stent | 1 yr | Stent exchange and cholecistectomy | - |
Guerrero Hernández et al[36], 2005 | M, 29 yrs | CBD stenosis | ERBD + Sugiura | - | - | - |
Rosenthal et al[37], 2008 | F, 44 yr | CBD stenosis and stones | Stent + SE | - | PSS | - |
Ajayi et al[38], 2009 | F, 13 yr | Stenosis | ES + BD + stent | 6 mo | Multiple stent exchange | - |
Layec et al[39], 2009 | F, 74 yr | Stenosis | Metallic stent | 18 mo | Metallic stent | Haemobilia |
Sharma et al[40], 2009 | M, 35 yr F, 30 yr M, 25 yr | CBD stenosis 3 | ES+SE 3 | - | - | Haemobilia 3 |
Vasiliadis et al[41], 2009 | F, 39 yr | CBD stenosis | ES | 19 mo | Multiple stent exchange→PSS + cholecistectomy | - |
Cantù et al[42], 2010 | M, 31 yr | CBD stenosis | ES + stent | 4 yr | - | - |
Martinez et al[43], 2011 | M, 34 yr | IE diltaions | Stent | - | - | - |
Mistry et al[44], 2012 | M, 28 yr | CBD stenosis | BD + BA + PTBD | - | Percutaneous transhepatic-gastrostomy | Haemobilia |
Alam et al[45], 2012 | M, 30 yr F, 19 yr | CBD stenosis 2 GB stones 1 CBD stones 1 | PTBD Stent | - | Cholecistectomy | - |
D’Souza et al[46], 2013 | M, 49 yr | CBD stenosis | Stent + BD (after stent removal) | - | PSS + splenectomy | Haemobilia (post-biopsy) |
Bernon et al[47], 2014 | M, 36 yr | CBD stenosis and stones | SE + stent | 1 yr | Stent exchange→PTBD→cholecistectomy, intrahepatic 3 semgment bypass | Cholangitis |
Hyun et al[26], 2015 | M, 33 yr | CBD stenosis | ERBD→PTBD + portal stent | 3 mo | - | Haemobilia |
Table 4 Surgical management of portal biliopathy: summary of case series and case reports
Ref. | No. of patients | Biliary abnormalities | First treatment | Follow-up | Further treatments | Complications/outcome |
Chaudhary et al[53], 1998 | 9 symptomatic | Stenosis: 2 CBD stones: 2 | BA 2 SRS 7 | 9 pts - | BA 2 Stent 1 ES + SE 2 | Death 1 Resolution 7 |
Condat et al[3], 2003 | 7 symptomatic | Cholecystitis/right hypocondrial pain 4 Cholangitis 1 Stenosis 2 | Cholecystostomy + ERCP 1 Stent 1 BA+PTBD 1 | 4-25 mo | - | Haemobilia 1 |
Gauthier-Villars et al[19], 2005 | 8 symptomatic (pediatric) | Stenosis 6 Biliarydilation 8 | - PSS 8 | 8 pts 4.5-15 yr | - | Complete resolution 7 Partial resolution 1 |
Khare et al[25], 2005 | 13 symptomatic | A: Stenosis 5 B: CBD stones 3 C: Stenosis + CBD stones 5 | A: PSS 4; BA 1 B: ERCP 2; PSS + BA 1 C: Unsuccessful ERCP 4; PSS 3; Splenectomy + devasc 2 | - | A: Multiple ERCP: 1 B: Splenectomy 1 (post-ERCP) C: Multiple ERCP 2; BA 1; Splenectomy + BA 1 | Death 1 |
Vibert et al[30], 2007 | 19 symptomatic | IE biliary dilation 9 IE stones 7 CBD stones 4 | PSS group: PTBD 1 SRS 10 NPSS group: ES + stent 2 ES + SE 1 PTBD 6 BA 4 | 19 pts 4-30 mo | PSS group: BA 5 NPSS group PTBD 1 after ERCP and 4 after BA | Resolution 17 Death 3 |
Dhiman et al[2], 2007 | 12 symptomatic | Stenosis: 7 CBD stones: 5 Choledochal varices 2 Mirizzi’ssyndrome 1 | PSS 5 ES 3 ES + dilation 2 Stent 4 | 19 mo (range 6-132) | Multiple stent exchange in pts initially treated with stent | Cholangitis in 2 pts treated with stent |
D’Souza et al[54], 2009 | 1 symptomatic | CBD stenosis + GB stones | Pre-surgery stent→PSS + BA (single stage) | 18 mo | - | Resolution |
Camerlo et al[51], 2010 | 3 symptomatic | Stenosis 3 | PSS 3 Stent 1 (pre-PSS) | 3 pts 2-13 yr | - | Resolution 3 |
Agarwal et al[55], 2011 | 39 symptomatic | Stenosis 15 CBD stones 7 GB stones 12 IE dilation 39 | SRS 37 BA 2 | 37 pts 32 mo | ES ± SE 10 BA 12 ES + cholecystectomy 1 | Resolution 35 |
Chattopadhyay et al[52], 2012 | 24 symptomatic 32 asymptomatic | CBD stenosis 3 Multiple stenosis 5 IE dilation 14 CBD stones 7 GB stones 11 | ERCP pre-surgery 12 PSS 40 Splenectomy + devasc. 16 | 43 pts 48 mo (range 14-120) | ES + SE 2 Multiple ES + stent 5 BA 2 | Resolution 38 Death 1 |
Suárez et al[56], 2013 | 3 symptomatic | Stenosis 3 | UDCA 1 BA 1 | - | - | - |
Bhatia et al[57], 2014 | 2 symptomatic | GB stones | Cholecistectomy | - | - | Resolution |
Liu et al[58], 2015 | 18 | Stenosis 6 Dilations 6 Stenosis + dilations 6 | PSS 18 | - | - | Resolution 15 |
- Citation: Franceschet I, Zanetto A, Ferrarese A, Burra P, Senzolo M. Therapeutic approaches for portal biliopathy: A systematic review. World J Gastroenterol 2016; 22(45): 9909-9920
- URL: https://www.wjgnet.com/1007-9327/full/v22/i45/9909.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i45.9909